Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Glycine recalled?

Yes — there is an active recall. 9 ongoing FDA recalls mention Glycine (12 total). Check the affected lots below.

Most common reason: Sterility / contamination (7 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Glycine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Glycine recalls in 2026

6 initiated in 2026, 12 in total — newest first
Class II · Moderate risk

SEMAGLUTIDE 20mg

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Ongoing Particulate / foreign matter Apollo Care, LLC NDC 71170-724-04 D-0757-2026
Class II · Moderate risk

SEMAGLUTIDE 10mg

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Ongoing Particulate / foreign matter Apollo Care, LLC NDC 71170-722-02 D-0756-2026
Class II · Moderate risk

SEMAGLUTIDE 7.5mg

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Ongoing Particulate / foreign matter Apollo Care, LLC NDC 71170-721-01 D-0755-2026
Class II · Moderate risk

SEMAGLUTIDE 5mg

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Ongoing Particulate / foreign matter Apollo Care, LLC NDC 71170-712-03 D-0754-2026
Class II · Moderate risk

SEMAGLUTIDE 2.5mg

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Ongoing Particulate / foreign matter Apollo Care, LLC NDC 71170-711-02 D-0753-2026
Class II · Moderate risk

Glycine Injection

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-0344-3 D-0955-2020
Class II · Moderate risk

Glycine 50 Mg/Ml Injectable

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

Terminated Sterility / contamination Beacon Hill Medical Pharmacy, P.C. D-964-2013
Class II · Moderate risk

1.5% Glycine Irrigation

Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags.

Terminated Sterility / contamination Hospira Inc. NDC 0409-7974-08 D-618-2013